DK0948604T3 - Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet - Google Patents
Screeningsmetoder for forbindelser som binder til PYK2-polypeptidetInfo
- Publication number
- DK0948604T3 DK0948604T3 DK97952333T DK97952333T DK0948604T3 DK 0948604 T3 DK0948604 T3 DK 0948604T3 DK 97952333 T DK97952333 T DK 97952333T DK 97952333 T DK97952333 T DK 97952333T DK 0948604 T3 DK0948604 T3 DK 0948604T3
- Authority
- DK
- Denmark
- Prior art keywords
- bind
- compounds
- screening methods
- features
- pyk2 polypeptide
- Prior art date
Links
- 101000878540 Homo sapiens Protein-tyrosine kinase 2-beta Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000012216 screening Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 102100037787 Protein-tyrosine kinase 2-beta Human genes 0.000 abstract 2
- 230000019491 signal transduction Effects 0.000 abstract 2
- 230000005856 abnormality Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Detergent Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Confectionery (AREA)
- Tires In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3282496P | 1996-12-11 | 1996-12-11 | |
| EP97952333A EP0948604B1 (en) | 1996-12-11 | 1997-12-09 | Screening methods for compounds binding to the Pyk2 polypeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0948604T3 true DK0948604T3 (da) | 2004-11-22 |
Family
ID=21867009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97952333T DK0948604T3 (da) | 1996-12-11 | 1997-12-09 | Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20020048782A1 (da) |
| EP (1) | EP0948604B1 (da) |
| JP (1) | JP2001505779A (da) |
| AT (1) | ATE271603T1 (da) |
| AU (1) | AU5596998A (da) |
| CA (1) | CA2274805A1 (da) |
| DE (1) | DE69729954T2 (da) |
| DK (1) | DK0948604T3 (da) |
| ES (1) | ES2227729T3 (da) |
| PT (1) | PT948604E (da) |
| WO (1) | WO1998026054A2 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19860833C1 (de) * | 1998-12-30 | 2000-09-07 | Albrecht E Sippel | Methode zur zellulären High-Throughput(Hochdurchsatz)-Detektion von Rezeptor-Liganden-Interaktionen |
| AU2209899A (en) * | 1998-12-30 | 2000-07-24 | Sugen, Inc. | Pyk2 (raftk) and inflammation |
| US6861442B1 (en) | 1998-12-30 | 2005-03-01 | Sugen, Inc. | PYK2 and inflammation |
| EP1630559A3 (en) * | 1998-12-30 | 2006-06-07 | Sugen, Inc. | PYK2 (RAFTK) and inflammation |
| JP2003510010A (ja) * | 1999-02-22 | 2003-03-18 | スージェン・インコーポレーテッド | Ｐｙｋ２結合蛋白質 |
| DE10037759A1 (de) * | 2000-08-03 | 2002-07-04 | Gruenenthal Gmbh | Screeningverfahren |
| EP1228766A1 (en) * | 2001-01-31 | 2002-08-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | PYK2 phosphorylation by HER3 induces tumor invasion |
| DE10123055A1 (de) * | 2001-05-11 | 2003-03-20 | Gruenenthal Gmbh | Screeningverfahren mit PIM1-Kinase oder PIM3-Kinase |
| DE10128541A1 (de) * | 2001-06-13 | 2003-02-20 | Gruenenthal Gmbh | Screening-Verfahren mit BNPI und DNPI |
| AU2002358267A1 (en) * | 2001-12-19 | 2003-07-09 | Millennium Pharmaceuticals, Inc. | Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| US20040171062A1 (en) * | 2002-02-28 | 2004-09-02 | Plexxikon, Inc. | Methods for the design of molecular scaffolds and ligands |
| CN1681939A (zh) * | 2002-09-19 | 2005-10-12 | 辉瑞产品公司 | 可诱导的粘着斑激酶细胞试验 |
| WO2004078923A2 (en) * | 2003-02-28 | 2004-09-16 | Plexxikon, Inc. | Pyk2 crystal structure and uses |
| WO2005002573A2 (en) * | 2003-06-06 | 2005-01-13 | Elan Pharmaceuticals, Inc. | Methods for using modulators of proline-rich tyrosine kinase 2 |
| US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| AR056857A1 (es) | 2005-12-30 | 2007-10-24 | U3 Pharma Ag | Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos |
| WO2009155060A2 (en) * | 2008-05-28 | 2009-12-23 | Mayo Foundation For Medical Education And Research | Anti-pyk2 antibodies |
| MX358013B (es) | 2009-11-13 | 2018-08-01 | Amgen Inc | Materiales y metodos para el tratamiento o prevencion de enfermedades asociadas al her-3. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4343940A (en) * | 1979-02-13 | 1982-08-10 | Mead Johnson & Company | Anti-tumor quinazoline compounds |
| DE3069468D1 (en) * | 1979-12-19 | 1984-11-22 | Nat Res Dev | Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents |
| DE3611194A1 (de) * | 1986-04-04 | 1987-10-08 | Bayer Ag | Cancerostatisches mittel |
| DE3920029C2 (de) * | 1988-06-30 | 1999-05-20 | Clariant Finance Bvi Ltd | Farbstoffe zum Färben von Kunststoffen |
| US5837815A (en) * | 1994-12-15 | 1998-11-17 | Sugen, Inc. | PYK2 related polypeptide products |
| US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
-
1997
- 1997-12-09 AT AT97952333T patent/ATE271603T1/de not_active IP Right Cessation
- 1997-12-09 DE DE69729954T patent/DE69729954T2/de not_active Expired - Fee Related
- 1997-12-09 AU AU55969/98A patent/AU5596998A/en not_active Abandoned
- 1997-12-09 EP EP97952333A patent/EP0948604B1/en not_active Expired - Lifetime
- 1997-12-09 ES ES97952333T patent/ES2227729T3/es not_active Expired - Lifetime
- 1997-12-09 DK DK97952333T patent/DK0948604T3/da active
- 1997-12-09 PT PT97952333T patent/PT948604E/pt unknown
- 1997-12-09 WO PCT/US1997/022565 patent/WO1998026054A2/en not_active Ceased
- 1997-12-09 US US08/987,689 patent/US20020048782A1/en not_active Abandoned
- 1997-12-09 CA CA002274805A patent/CA2274805A1/en not_active Abandoned
- 1997-12-09 JP JP52689998A patent/JP2001505779A/ja not_active Withdrawn
-
2002
- 2002-11-13 US US10/292,524 patent/US20030119067A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0948604B1 (en) | 2004-07-21 |
| DE69729954T2 (de) | 2005-09-08 |
| US20030119067A1 (en) | 2003-06-26 |
| CA2274805A1 (en) | 1998-06-18 |
| JP2001505779A (ja) | 2001-05-08 |
| EP0948604A2 (en) | 1999-10-13 |
| WO1998026054A2 (en) | 1998-06-18 |
| DE69729954D1 (de) | 2004-08-26 |
| ES2227729T3 (es) | 2005-04-01 |
| US20020048782A1 (en) | 2002-04-25 |
| PT948604E (pt) | 2004-10-29 |
| WO1998026054A3 (en) | 1998-09-03 |
| AU5596998A (en) | 1998-07-03 |
| ATE271603T1 (de) | 2004-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0948604T3 (da) | Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet | |
| WO1996018738A3 (en) | PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES | |
| DE69635740D1 (de) | Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen | |
| DE69926731D1 (de) | Diagnose und behandlung von aur1 und/oder aur2 verwandten erkrankungen | |
| DK0755446T3 (da) | Cardiotrophin og anvendelser deraf | |
| WO1998022589A3 (en) | Survivin, a protein that inhibits cellular apoptosis, and its modulation | |
| NZ296748A (en) | Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods | |
| ATE135371T1 (de) | Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis | |
| ATE313802T1 (de) | Bestimmung von adrenomedullin-bindenden proteinen | |
| ATE483806T1 (de) | Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide | |
| WO1998014596A3 (en) | Disease associated protein tyrosine phosphatases | |
| DE69934324D1 (de) | Behandlung von entzündungskrankheiten | |
| EP0261403A3 (de) | Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle | |
| DE69734890D1 (de) | Rdgb-proteine | |
| ATE301712T1 (de) | Z2-19a, ein menschliches homolog von dem protein 2-19 | |
| DE69929683D1 (de) | Antisense modulierung von lfa-3 | |
| DK0870036T3 (da) | Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor | |
| ATE309371T1 (de) | Protein mit dnase-aktivität | |
| WO2004007536A3 (en) | Interactions of the epstein-barr virus protein ebna1, and uses thereof | |
| DE3888216D1 (de) | Methode zur Herstellung von aminokohlenwasserstoff-substituierten Ketoximosilanen. | |
| NO20000345L (no) | Humankloridionekanal-zsig44 | |
| WO2002088345A3 (en) | Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene | |
| ATE104344T1 (de) | Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden. |